§ Mr. SayeedTo ask the Secretary of State for Health whether, in view of the publication by the European Bureau of Consumer Unions of comparative drug costs in European Community states, he has anything to add to his answer of 26 January,Official Report, column 712.
154W
§ Mr. Mellor[holding answer 29 June 1989]: I have nothing of substance to add to my response to the earlier question to which my hon. Friend refers. The latest analysis of prices by the European Bureau of Consumer Unions, which I understand updates the material in an earlier study by the same organisation, is the most recent in a series of such studies by various organisations produced over several years which have generally indicated a similar pattern of overall price differentials for pharmaceutical products in the different member states of the European Community.